- 4.9Impact Factor
- 9.0CiteScore
- 21 daysTime to First Decision
Peripheral Neuropathies: Molecular Research and Novel Therapy—2nd Edition
This special issue belongs to the section “Molecular Neurobiology“.
Special Issue Information
Dear Colleagues,
The quality of life of those with peripheral neuropathies is undermined by their various symptoms, such as pain and numbness of the extremities, muscle weakness, and autonomic disorders. The neuropathies are caused by gene mutations, immune system disorders, metabolic abnormalities, cancers and anti-cancer drugs, and other systemic diseases; however, the onset and progression mechanisms remain largely unclear and the efficacious remedies against them have not yet been developed. This Special Issue provides a platform for researchers pursuing the molecular pathogenesis of peripheral neuropathies and novel therapeutic approaches toward them. Detailed information is available from the findings of recent research on inherited neuropathy (e.g., Charcot–Marie–Tooth disease, hereditary ATTR amyloidosis, and Fabry disease), diabetic polyneuropathy, immune-mediated neuropathy (e.g., Guillain–Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and autoimmune autonomic ganglionopathy), and drug-induced neuropathy (e.g., anti-cancer drugs including immune checkpoint inhibitors, amiodarone, and tumor necrosis factor-a antagonists). Basic studies regarding axonal degeneration, demyelination, and neuron–Schwann cell interplay under physiological and pathophysiological conditions are also welcome for submission.
Dr. Zhidong Zhou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- axonal degeneration
- demyelination
- schwann cells
- dorsal root ganglia
- diabetic neuropathy
- chemotherapy-induced peripheral neuropathies
- immune-mediated neuropathies
- immune checkpoint inhibitors
- charcot-marie-tooth disease
- autonomic neuropathies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

